336 related articles for article (PubMed ID: 32876693)
1. Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic.
Prescott HC; Rice TW
JAMA; 2020 Oct; 324(13):1292-1295. PubMed ID: 32876693
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
[TBL] [Abstract][Full Text] [Related]
3. Inhaled corticosteroids in virus pandemics: a treatment for COVID-19?
Nicolau DV; Bafadhel M
Lancet Respir Med; 2020 Sep; 8(9):846-847. PubMed ID: 32738928
[No Abstract] [Full Text] [Related]
4. Corticosteroid use in selected patients with severe acute respiratory distress syndrome related to COVID-19.
Goursaud S; Descamps R; Daubin C; du Cheyron D; Valette X
J Infect; 2020 Aug; 81(2):e89-e90. PubMed ID: 32417314
[No Abstract] [Full Text] [Related]
5. Simultaneous ventilation of two simulated ARDS patients in COVID-19 pandemic.
Epstein D; Hoffman Y; Dahoud G; Raz A; Miller A
Crit Care; 2020 May; 24(1):214. PubMed ID: 32393390
[No Abstract] [Full Text] [Related]
6. On the use of corticosteroids for 2019-nCoV pneumonia.
Shang L; Zhao J; Hu Y; Du R; Cao B
Lancet; 2020 Feb; 395(10225):683-684. PubMed ID: 32122468
[No Abstract] [Full Text] [Related]
7. Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective.
Halpin DMG; Singh D; Hadfield RM
Eur Respir J; 2020 May; 55(5):. PubMed ID: 32341100
[TBL] [Abstract][Full Text] [Related]
8. Corticosteroids and the hyper-inflammatory phase of the COVID-19 disease.
Taboada M; Caruezo V; Naveira A; Atanassoff PG
J Clin Anesth; 2020 Nov; 66():109926. PubMed ID: 32474331
[No Abstract] [Full Text] [Related]
9. Can spironolactone be used to prevent COVID-19-induced acute respiratory distress syndrome in patients with hypertension?
Cadegiani FA
Am J Physiol Endocrinol Metab; 2020 May; 318(5):E587-E588. PubMed ID: 32297520
[No Abstract] [Full Text] [Related]
10. Corticosteroids, COVID-19 pneumonia, and acute respiratory distress syndrome.
Matthay MA; Wick KD
J Clin Invest; 2020 Dec; 130(12):6218-6221. PubMed ID: 32976118
[TBL] [Abstract][Full Text] [Related]
11. Patient with severe COVID-19 treated with corticosteroids.
Ofstad EH; Hauglid T; Tollåli T; Vasiljevic KR; Dybwik K
Tidsskr Nor Laegeforen; 2020 Sep; 140(12):. PubMed ID: 32900168
[TBL] [Abstract][Full Text] [Related]
12. Mortality in COVID-19 patients with acute respiratory distress syndrome and corticosteroids use: a systematic review and meta-analysis.
Hasan SS; Capstick T; Ahmed R; Kow CS; Mazhar F; Merchant HA; Zaidi STR
Expert Rev Respir Med; 2020 Nov; 14(11):1149-1163. PubMed ID: 32734777
[TBL] [Abstract][Full Text] [Related]
13. Audio Interview: Dexamethasone and Covid-19.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Jul; 383(4):e52. PubMed ID: 32706553
[No Abstract] [Full Text] [Related]
14. Efficacy of dexamethasone treatment for patients with the acute respiratory distress syndrome caused by COVID-19: study protocol for a randomized controlled superiority trial.
Villar J; Añón JM; Ferrando C; Aguilar G; Muñoz T; Ferreres J; Ambrós A; Aldecoa C; Suárez-Sipmann F; Thorpe KE; Jüni P; Slutsky AS;
Trials; 2020 Aug; 21(1):717. PubMed ID: 32799933
[TBL] [Abstract][Full Text] [Related]
15. Corticosteroid therapy for coronavirus disease 2019-related acute respiratory distress syndrome: a cohort study with propensity score analysis.
Wu C; Hou D; Du C; Cai Y; Zheng J; Xu J; Chen X; Chen C; Hu X; Zhang Y; Song J; Wang L; Chao YC; Feng Y; Xiong W; Chen D; Zhong M; Hu J; Jiang J; Bai C; Zhou X; Xu J; Song Y; Gong F
Crit Care; 2020 Nov; 24(1):643. PubMed ID: 33172477
[TBL] [Abstract][Full Text] [Related]
16. Management of Respiratory Distress Syndrome due to COVID-19 infection.
Navas-Blanco JR; Dudaryk R
BMC Anesthesiol; 2020 Jul; 20(1):177. PubMed ID: 32689937
[TBL] [Abstract][Full Text] [Related]
17. Acute respiratory distress syndrome and steroids in the shadow of coronavirus disease 2019.
Jaeschke R
Pol Arch Intern Med; 2020 Apr; 130(4):266-267. PubMed ID: 32383835
[No Abstract] [Full Text] [Related]
18. [Not Available].
Kan B; Ahl M; Blennow O; Eriksson P; Nowak P; Parke Å; Stojanovic B; Tovatt T; Vesterbacka J
Lakartidningen; 2020 Oct; 117():. PubMed ID: 33021326
[No Abstract] [Full Text] [Related]
19. Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.
Georgiev T
Rheumatol Int; 2020 May; 40(5):825-826. PubMed ID: 32232552
[No Abstract] [Full Text] [Related]
20. A Review of the Evidence for Corticosteroids in COVID-19.
Johns M; George S; Taburyanskaya M; Poon YK
J Pharm Pract; 2022 Aug; 35(4):626-637. PubMed ID: 33719698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
